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Though the 2009 worldwide influenza A (H1N1) pandemic has been declared to 
have ended, the influenza virus is expected to continue to circulate from some years 
as a seasonal influenza. A rapid antigen test (RAT) can aid in rapid diagnosis and al-
low for early antiviral treatment. We evaluated the clinical usefulness of RAT using 
SD Bioline Influenza Antigen Test® kit to detect the influenza virus, considering vari-
ous factors. From August 1, 2009 to October 10, 2009, a total of 938 patients who 
visited the outpatient clinic at Korea University Guro Hospital with influenza-like ill-
nesses were enrolled in the study. Throat or nasopharyngeal swab specimens were 
obtained from each of the patients. Using these specimens, we evaluated the influen-
za detection rate by rapid antigen test based on the real-time reverse-transcriptase 
polymerase chain reaction (rRT-PCR) method. In comparison with rRT-PCR, the 
sensitivity and specificity of the RAT were 44.0% and 99.9%, respectively. The cy-
clic threshold values of RAT negative specimens were higher than RAT positive 
specimens (30.1±3.1 vs. 28.3±3.9, p=0.031). The sensitivity of the RAT kit was high-
er in patients who visited clinics within two days of symptom onset (60.4% vs. 
11.1%, p=0.026). The results of this study show that the RAT cannot be recommend-
ed for general use in all patients with influenza-like illness because of its low sensitiv-
ity. The RAT may be used, only in the settings with limited diagnostic resources, for 
patients who visit a clinic within two days of symptom onset.
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Since the World Health Organization (WHO) declared a worldwide pandemic due 
to the 2009 influenza A (H1N1) virus on 11 June 2009, this influenza virus has been 
prevalent in most countries of the world. Though the influenza pandemic was de-
clared to be over by WHO on 10 August 2010, localized outbreaks of the virus in-
fection still occur. Rapid diagnosis of the influenza is important for initiation of an-
tiviral treatment and implementation of infection control measures. Real-time 
reverse transcriptase polymerase chain reaction (rRT-PCR) is used as the standard Won Suk Choi, et al.
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glutinin gene, were positive but the rRT-PCR for human H1 
and H3 was negative. Cyclic threshold (Ct) values were 
checked to evaluate the amount of virus in the specimens, 
with lower values indicating higher viral titers.
Among the 938 patients tested, 266 (28.4%) were con-
firmed as having a novel influenza A (H1N1) virus infec-
tion by rRT-PCR. Among the 266 PCR-confirmed patients, 
117 (44.0%) were positive for influenza A virus by the RAT 
kit. Among 672 PCR-negative patients, only one was posi-
tive for influenza A virus by the RAT kit. In comparison with 
rRT-PCR, RAT had sensitivity of 44.0%, specificity of 
99.9%, positive predictive value of 99.2% and negative pre-
dictive value of 81.8% (Table 1). The Ct values in the RAT 
negative specimens were significantly higher than in the 
RAT positive specimens (30.1±3.1 vs. 28.3±3.9, p=0.031).
Among the 938 patients, 458 (48.8%) were examined by 
RAT with swab specimens from both the throat and naso-
pharynx. Among them, 164 (35.8%) cases were confirmed 
as 2009 influenza A (H1N1) virus infection by rRT-PCR. 
Of the 164 patients confirmed by rRT-PCR, 81 (49.4%) 
were positive on the RAT: 14 (8.5%) were positive for RAT 
only on the throat specimen, 33 (20.1%) were positive for 
RAT only on the nasopharyngeal specimen, and 34 (20.7%) 
were positive for RAT on both the throat and nasopharyn-
geal specimens. The RAT positive rate was relatively high-
er in the nasopharyngeal specimens than in the throat speci-
mens although there was no statistical significance (40.9% 
vs. 29.3%). When RAT results were stratified according to 
elapsed time from onset of ILI, the sensitivity was remark-
ably higher in patients who visited clinics within two days 
of symptom onset (60.4% vs. 11.1%, p=0.026) (Table 2).
The SD Bioline Influenza Antigen Test® is a lateral-flow 
immunoassay that uses influenza virus-specific monoclonal 
diagnostic test for the pandemic influenza virus. However, 
rRT-PCR is expensive, requires specialized equipments and 
trained expertise, and requires some time for reporting. The 
rapid antigen test (RAT) can help rapidly diagnose the in-
fluenza virus infection because the test requires minimum 
training to perform and the results are reported within 15-
30 minutes. Several RAT kits have been evaluated for 2009 
influenza A (H1N1) virus, with reported sensitivities rang-
ing from 38.3% to 77.0% and specificities ranging from 
84.0% to 100% compared to rRT-PCR.1-4 However, the di-
agnostic value of RAT may differ according to specimen 
type, elapsed time from symptom onset, and amount of vi-
rus in a specimen.5 In this study, we evaluated the clinical 
usefulness of SD Bioline Influenza Antigen Test® (Standard 
Diagnostic, Inc., Suwon, Korea) for detecting the 2009 in-
fluenza A (H1N1) virus, considering the various factors.
From August 1, 2009 to October 10, 2009, a total of 938 
patients who visited the outpatient clinic at Korea University 
Guro Hospital with influenza-like illness (ILI), were enrolled 
in the study. All patients were over 15 years of age. ILI was 
defined as a fever of greater than 37.8°C with one or more 
respiratory symptoms, e.g., cough, sore throat, etc., in the ab-
sence of another cause. Demographic and clinical data, e.g., 
age, sex, symptoms and elapsed time from symptom onset, 
were collected using a case report form. Written informed 
consent to participate in the study was obtained from all pa-
tients or one of the patient’s parents for those younger than 
20 years of age. The study protocol was approved by the hos-
pital ethics committee (approval No. 09999).
One throat and two nasopharyngeal swabs specimens 
were obtained from each of the patients. One throat speci-
men and one nasopharyngeal specimen were tested with 
the RAT kit at the outpatient clinic. The other nasopharyn-
geal specimen was immediately transferred to the virus lab-
oratory and tested with rRT-PCR.
RAT was carried out according to the manufacturer’s in-
structions at the outpatient clinic. A pink-to-purple test line 
in the A region with the presence of a control line indicated 
a positive result. The rRT-PCR was performed quantitative-
ly according to the WHO recommendations using the Ad-
vanSure Influenza A/Influenza A H1N1 kit (LG Life Sci-
ence, Seoul, Korea).6 The AdvanSure rRT-PCR kit had 
been tested in a previous study, and the results showed the 
concordance rate for multiplex PCR and the rRT-PCR kit to 
be 99.6%.7 A sample was considered positive if the results 
from tests using two different rRT-PCR targets, e.g., prim-
ers specific for universal M gene and pandemic H1 haemag-
Table 1. Performance of Rapid Antigen Test (RAT) using SD 
Bioline Influenza Antigen Test
® Kit Compared to rRT-PCR for 
the Detection of the 2009 influenza A(H1N1) virus
rRT-PCR
Total
Positive Negative
RAT*
    Positive 117     1 118
    Negative 149 671 820
Total 226 672 938
rRT-PCR, real-time reverse transcriptase polymerase chain reaction.
*The sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) of the RAT were 44.0%, 99.9%, 99.2% and 81.8%, 
respectively. The PPV and NPV were calculated based only on the data of 
this table, without considering the true prevalence of the 2009 influenza 
A (H1N1) Virus; the PPV was calculated as 117 divided by 118 and the NPV 
was calculated as 671 divided by 820.Rapid Antigen Test for Detecting the 2009 Influenza A (H1N1) Virus 
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access to diagnostic resources. As the RAT missed 40% of 
cases, it would be appropriate to manage patients as pre-
sumptive cases while awaiting the rRT-PCR results. This is 
particularly important for patients at risk of severe influen-
za, such as elderly or pregnant patients, or where there is a 
high risk of transmission.
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antibodies. It can detect the influenza A and B viruses quali-
tatively. In this study, the RAT kit showed relatively low 
sensitivity for the detection of the 2009 influenza A (H1N1) 
virus, as compared to a previous study of seasonal influenza 
virus detection.8 However, specificity, PPV and NPV of the 
RAT for the detection of the novel influenza A (H1N1) vi-
rus was considerably higher during the 2009 influenza 
A(H1N1) pandemic. Moreover, sensitivity of the RAT was 
improved for patients who visited clinics within two days of 
symptom onset. The improved sensitivity of the RAT may 
have been due to high viral titer during early infection.
This study has some limitations. First, it was performed 
only in the outpatient clinic of single university hospital. 
Second, the rRT-PCR was done only on one NP swab spec-
imen from each patient. Because 14 patients were positive 
for RAT only with throat specimens, it is possible that the 
rRT-PCR might have picked up more positives if it had 
been done on the throat swabs as well. However, using rRT-
PCR on nasopharyngeal swab specimens might be a rea-
sonable way of identifying infected patients because rRT-
PCR on those specimens is very sensitive for detecting the 
2009 influenza A (H1N1) virus.9 
The results of this study show that the RAT using the SD 
Bioline Influenza Antigen Test® cannot be recommended 
for general use in all patients with ILI because of its low 
sensitivity. Moreover, the additional cost of the RAT kit can 
be a burden to patients because negative results require con-
firmatory assays of greater sensitivity, such as rRT-PCR. In 
the situation of an early pandemic, when the optimal mono-
clonal antibody against novel influenza antigen is not avail-
able, RAT may be useful only in settings that have limited 
Table 2. Performance of Rapid Antigen Test (RAT) Using the 
SD Bioline Influenza Antigen Test
® Kit for the Detection of the 
2009 influenza A(H1N1) virus according to Elapsed Time from 
Symptom Onset
Elapsed time from symptom onset 
(days)
Total
  ≤2
≥3
  0   1   2
RAT
    Positive 19 36 23   4 81
    Negative 12 17 22 32 83
Sensitivity (%)* 60.4 11.1 49.2
*Difference was statistically significant (p=0.026).